Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

Women with endometrial cancer (EC) frequently receive adjuvant paclitaxel and carboplatin (PC) chemotherapy. There is no standard first line chemotherapy at disease recurrence. Data extrapolated from ovarian cancer has suggested that patients with recurrent EC may benefit from further platinum-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubinstein, Maria, Halpenny, Darragh, Makker, Vicky, Grisham, Rachel N., Aghajanian, Carol, Cadoo, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461565/
https://www.ncbi.nlm.nih.gov/pubmed/31011610
http://dx.doi.org/10.1016/j.gore.2019.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461565/
https://www.ncbi.nlm.nih.gov/pubmed/31011610
http://dx.doi.org/10.1016/j.gore.2019.04.002

Ejemplares similares